Vaccines, Blood & Biologics
DACS SC (Buoyant Density Solution 60)
Product: DACS SC (Buoyant Density Solution 60)
Applicant: Dendreon Corp., Seattle, WA
PMA number: BP970003
Indication for Use: Processing autologous mobilized peripheral blood progenitor cells (PBPC) collected by leukapheresis to reduce RBC, platelets and granulocytes in the final PBPC product.
Approval Date: 7/23/99
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448

